Skip to main content

Advertisement

SpringerLink
Log in

Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

A broad spectrum of diseases are associated with IgM monoclonal gammopathy, including Waldenstrom macroglobulinemia (WM), various types of B cell non-Hodgkin’s lymphoma (NHL), multiple myeloma (MM), primary amyloidosis (AL), and monoclonal gammopathy of undetermined significance (MGUS); these are called IgM monoclonal gammopathy related diseases (IgM-RD). We investigated MYD88 L265P and WHIM-like CXCR4 mutations in various IgM-RD. Patients with serum immunofixation electrophoresis confirmed IgM monoclonal gammopathy who had enough material for DNA extraction and presented between January 2008 and October 2016 at Peking Union Medical College Hospital were enrolled in this cohort. We performed real-time allele-specific-polymerase chain reaction and Sanger sequencing to explore the presence of MYD88 L265P and WHIM-like CXCR4 mutations. One hundred and twelve patients (64 male and 48 female patients) were included in this retrospective study. The median age at diagnosis was 62 years (range, 30–84 years). In total, 64 patients (57.1%) carried the MYD88 L265P mutation and 14 patients (12.5%) carried the CXCR4 WHIM-like mutation. We identified the MYD88 L265P somatic variant in cases with WM (39/42), MGUS (8/18), NHL (14/41, including 4/13 diffuse large B cell lymphoma (DLBCL), 1/8 mucosa-associated lymphoid tissue, 3/6 splenic marginal zone lymphoma (SMZL), 1/4 chronic lymphocytic leukemia, 2/3 nodal marginal zone lymphoma (NMZL), 1/2 mantle cell lymphoma, 1 Burkitt lymphoma, and 1 B cell NHL that could not be classified), primary AL (2/2), and IgM-PN (1/1). The mutation was absent in five patients with Cryoglobulinemia, two with primary cold agglutinin disease and one with MM. The CXCR4 WHIM-like mutation was present in 10/42 patients with WM, 3/41 with NHL (1 DLBCL, 1 SMZL, and 1 NMZL), and 1/18 patients with IgM MGUS. Among the patients with NHL, those with the mutated MYD88 L265P genotype were younger and had lower level of IgG and IgA than the patients with the wild-type genotype. Patients with the mutated MYD88 L265P genotype with WM and MZL were compared. More male patients, higher levels of IgM and lower levels of LDH were found in the WM group. There was no significant difference in overall survival between the two groups. We present a study of the prevalence of the MYD88 L265P mutation and CXCR4 WHIM-like mutation in IgM RD. The MYD88 L265P mutation may play a key role in the pathogenesis of IgM monoclonal gammopathies. It would be interesting in the future to use MYD88 mutation status to differentiate among diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cao XX, Meng Q, Mao YY et al (2016) The clinical spectrum of IgM monoclonal gammopathy: a single center retrospective study of 377 patients. Leuk Res 46:85–88

    Article  PubMed  Google Scholar 

  2. Treon SP, Xu L, Yang G et al (2012) MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N Engl J Med 367:826–833

    Article  CAS  PubMed  Google Scholar 

  3. Xu L, Hunter ZR, Yang G et al (2013) MYD88 L265P in Waldenstro ̈m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood 121:2051–2058

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Treon SP, Cao Y, Xu L et al (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenström macroglobulinemia. Blood 123:2791–2796

    Article  CAS  PubMed  Google Scholar 

  5. Owen RG, Treon SP, Al-Katib A et al (2003) Clinicopathological definition of Waldenstrom’s macroglobulinemia: consensus panel recommendations from the second international workshop on Waldenstrom’s macroglobulinemia. Semin Oncol 30:110–115

    Article  PubMed  Google Scholar 

  6. Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of Tumours of Haematopoitetic and lymphoid tissues. IARC PRESS, Lyon

    Google Scholar 

  7. Palumbo A, Avet-Loiseau H, Oliva S et al (2015) Revised international staging system for multiple myeloma: a report from international myeloma working group. J Clin Oncol 33:2863–2869

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Berentsen S, Tjønnfjord GE (2012) Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev 26:107–115

    Article  CAS  PubMed  Google Scholar 

  9. Manuel RC, John HS, Maria CC, Bosch X (2012) The cryoglobulinaemias. Lancet 379:348–360

    Article  Google Scholar 

  10. Roccaro AM, Sacco A, Jimenez C et al (2014) C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma. Blood 123:4120–4131

    Article  CAS  PubMed  Google Scholar 

  11. Varettoni M, Zibellini S, Arcaini L et al (2013a) MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance. Blood 122:2284–2285

    Article  CAS  PubMed  Google Scholar 

  12. Staiger AM, Ott MM, Parmentier S et al (2015) Allele-specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples. Br J Haematol 171:145–148

    Article  CAS  PubMed  Google Scholar 

  13. Liu F, Karube K, Kato H et al (2012) Mutation analysis of NF-kappa B signal pathway-related genes in ocular MALT lymphoma. Int J Clin Exp Pathol 5:436–441

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Yan Q, Huang Y, Watkins AJ et al (2012) BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica 97:595–598

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Puente XS, Pinyol M, Quesada V et al (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101–105

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Chakraborty R, Novak AJ, Ansell SM et al (2016) First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis. Blood 127:2936–2938

    Article  CAS  PubMed  Google Scholar 

  17. Randen U, Troen G, Tierens A et al (2014) Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica 99:497–504

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Varettoni M, Arcaini L, Zibellini S et al (2013b) Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom’s macroglobulinemia and related lymphoid neoplasms. Blood 121:2522–2528

    Article  CAS  PubMed  Google Scholar 

  19. Martinez-Lopez A, Curiel-Olmo S, Mollejo M et al (2015) MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol 39:644–651

    Article  PubMed  Google Scholar 

  20. Manasanch EE, Braylan R, Stetler-Stevenson M et al (2014) Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma. Leuk Lymphoma 55:1402–1403

    Article  PubMed  Google Scholar 

  21. Lin P, Hao S, Handy BC et al (2005) Lymphoid neoplasm associated with IgM paraprotein. A study of 382 patients. Am J Clin Pathol 123:200–205

    Article  PubMed  Google Scholar 

  22. Hunter ZR, Xu L, Yang G et al (2014) The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood 123:1637–1646

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China

    Xin-xin Cao, Qi Meng, Hao Cai, Tian-Hua He, Cong-li Zhang, Dao-bin Zhou & Jian Li

  2. Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China

    Wei Su

  3. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China

    Jian Sun

  4. Department of Hematology, Jiangsu Province Hospital, Nanjing, 210029, China

    Yue Li & Wei Xu

Authors
  1. Xin-xin Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qi Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hao Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tian-Hua He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cong-li Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jian Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yue Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Wei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dao-bin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jian Li.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Xin-xin Cao and Qi Meng have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, Xx., Meng, Q., Cai, H. et al. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Ann Hematol 96, 971–976 (2017). https://doi.org/10.1007/s00277-017-2968-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-017-2968-z

Keywords

Search

Navigation